Cost-effectiveness of coronary interventions

Heart

Volumn 78, Issue SUPPL.2, 1997, Pages 7-10

  Cohen, David J ^a,b   Sukin, Craig A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; ANTITHROMBOCYTIC AGENT;

ANGINA PECTORIS; ATHERECTOMY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; EXCIMER LASER; HOSPITAL COST; HUMAN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030670310     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.Suppl_2.7     Document Type: Review

References (21)

1. Parisi AF, Folland ED, Hartigan P. A comparsion of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326; 10-16.
2. Weinstein MC, Stason WB. Cest-effectiveness of coronary artery bypass surgery. Circulation 1982;66(suppl III): III56-66.
3. Goldman L, Sia STB, Cook EF, Rutherford JD, Weinstein MC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med 1988;319:152-7.
4. Krumholz HM, Pasternak RC, Weinstein MC, Friesinger GC, Ridker PM, Tosteson ANA, et al. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med 1992;327:7-13.
5. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716-21.
6. Goldman L, Gordon DJ, Rifkind BM, Hulley SB, Detsky AS, Goodman DW, et al. Cost and health implications of cholesterol lowering. Circulation 1992;85:1960-8.
7. Wong JB, Sonnenberg FA, Salem DN, Pauker SG. Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med 1990;113:852-71.
8. Weintraub WS, Mauldin PD, Becker E, Kosinski AS, King SB. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multi-vessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). Circulation 1995;92:2831-40.
9. Hlatky MA, Boothroyd DB, Winston CA, Brooks MM, Mark DB, Johnstone I. Factors affecting long-term cost in multivessel disease patients randomized to PTCA or CABG in the BARI Trial [abstract]. Circulation 1996; 94:I168.
10. Dick RJ, Popma JJ, Muller DW, Burek KA, Topol EJ. In-hospital costs associated with new percutaneous coronary devices. Am J Cardiol 1991;68:879-85.
11. Cohen DJ, Breall JA, Ho KKL, Weintraub RM, Kuntz RE, Weinstein MC, et al. The economics of elective coronary revascularization: comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting, and bypass surgery. J Am Coll Cardiol 1993;22: 1052-9.
12. Serruys PW, De Jaegere P, Kiemeneij F, Macay C, Rutsch W, Heyndricks G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
13. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331: 496-501.
14. Cohen DJ, Krumholz HM, Sukin CA, Ho KKL, Siegrist RB, Cleman M, et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: results from a randomized clinical trial. Circulation 1995;92:2480-7.
15. Sukin CA, Baim DS, Caputo RP, Ho KKL, Laham RJ, Flatley MG, et al. The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs. Am J Cardiol 1997;79:275-80.
16. Peterson ED, Cowper PA, Zidar JP, Phillips HR, Mark DB. In-hospital costs of coronary stenting (with or without coumadin) compared with angioplasty [abstract]. Circulation 1996;94:I325.
17. Cohen DJ, Breall JA, Ho KKL, Kuntz RE, Goldman L, Baim DS, et al. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease: use of a decision-analytic model. Circulation 1994;89:1859-74.
18. Ellis SG, Miller DP, Brown KJ, Omoigui N, Howell GL, Kutner M, Topol EJ. In-hospital cost of percutaneous coronary revascularization: critical determinants and implications. Circulation 1995;92:741-7.
19. Guzman LA, Simpfendorfer C, Fix J, Franco I, Whitlow PL. Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease. Am J Cardiol 1994;74:22-5.
20. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hofling B, Simonton CA, et al. A comparison of directional coronary atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med 1993;329:221-7.
21. Vandormael M, Reifart N, Preusler W, Schwarz F, Storger H, Hofman M, et al. Six month follow-up results following excimer laser angioplasty, rotational atherectomy, and balloon angioplasty for complex lesions: ERBAC Study [abstract]. Circulation 1994;90:I213.